The share of Canadian scientific publications in the top 10% of cited works in biotechnology is on a subtle decline from 2024 onwards, with a decrease from 10.31% in 2024 to 10.24% by 2028. Compared to the figures of 2023, this forecast indicates a slow reduction over the projected years, with a continuous minor decline year-on-year.

The average Compound Annual Growth Rate (CAGR) over the five years suggests a minimal average decrease per year. This upward trend indicates Canadian publications are maintaining a competitive presence, though with slight challenges in retaining their top-cited status over time.

Future trends to watch:

Potential shifts in research funding and focus areas could alter publication prominence.
International collaborations may boost citation impact.
Emerging technologies and innovation in biotechnology could influence citation frequencies.